Key result
Transaortic TAVI via right mini-thoracotomy shows similar in-hospital mortality compared to transfemoral TAVI.
Why the study?
Patients with unsuitable peripheral arterial anatomy require alternative transthoracic access for TAVI, and the safety and efficacy of transaortic TAVI via right mini-thoracotomy compared to transfemoral TAVI needed evaluation.
Does transaortic TAVI via right mini-thoracotomy yield comparable clinical outcomes to transfemoral TAVI in patients with severe aortic stenosis?
Observational (n=767)
No
Does transaortic TAVI via right mini-thoracotomy yield comparable clinical outcomes to transfemoral TAVI in patients with severe aortic stenosis?
Absolute Event Rate: 0% vs 1.5%
p-value: p=0.23
Transaortic TAVI via right mini-thoracotomy is a safe and feasible alternative to transfemoral TAVI for patients with unsuitable peripheral arterial access, demonstrating comparable 2-year clinical outcomes.
May support transaortic access safety in matched patients; leaves open randomized confirmation before wider adoption.
OBJECTIVES: Transcatheter aortic valve implantation (TAVI) via the transfemoral (TF) approach is widely used. However, patients with unsuitable peripheral arterial anatomy require alternative transthoracic access. In such patients, the transaortic TAVR via right mini-thoracotomy (Rt-TAo) approach offers a less invasive option than conventional sternotomy. Therefore, this study aimed to evaluate the procedural and 2-year clinical outcomes of TF TAVI versus Rt-TAo TAVI. METHODS: Patients who underwent TAVI via the TF approach or the Rt-TAo approach between January 2012 and November 2023 were retrospectively reviewed. Baseline characteristics and clinical outcomes were compared, and propensity score matching was performed to adjust for baseline differences. The primary end-points were in-hospital mortality, stroke, other periprocedural morbidities, and postprocedural length of hospitalization. Secondary end-points included overall survival, freedom from cardiac-related death, and major adverse cardiac and cerebrovascular events (MACCE) at 2 years. RESULTS: A total of 767 consecutive patients were included in the analysis, of whom 694 underwent TF TAVI and 73 underwent Rt-TAo TAVI. Before matching, the Rt-TAo group had higher baseline prevalences of comorbidities and Society of Thoracic Surgeon risk scores. After matching, the Rt-TAo group had a longer procedural time, higher transfusion requirements, and longer lengths of intensive care unit and total hospital stays. However, the 2 groups had similar rates of periprocedural stroke, coronary obstruction, annular rupture, access-related complications, and in-hospital mortality. The 2 groups had similar 2-year rates of survival and freedom from MACCE. CONCLUSIONS: The Rt-TAo TAVI is a safe and feasible alternative for patients with unsuitable peripheral arterial access, demonstrating comparable 2-year outcomes to TF TAVI.
No takes yet. Share an insight, caveat, or question.
Kawamoto et al. (2026) conducted an observational in Severe aortic stenosis (n=767). Transaortic TAVI via right mini-thoracotomy (Rt-TAo) vs. Transfemoral TAVI (TF) was evaluated on In-hospital mortality (propensity-matched cohort) (p=0.23). Transaortic TAVI via right mini-thoracotomy demonstrated similar rates of in-hospital mortality compared to transfemoral TAVI (0% vs 1.5%) in propensity-matched analysis, supporting its safety as an alternative access route for patients with unsuitable peripheral access.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: